54 results
6-K
EX-99.1
NNOX
Nano-X Imaging Ltd.
20 Aug 24
Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update
8:05am
liability, expenses related to an offering and legal fee in connection with the class-action litigation and the SEC investigation. A reconciliation between … to and the outcome of litigation Nanox is currently subject to and any similar or other claims and potential litigation it may be subject to in the future
6-K
EX-10.1
NNOX
Nano-X Imaging Ltd.
7 Jun 24
Report of Foreign Private Issuer
5:21pm
, claim, damage and expense whatsoever, as incurred, joint or several, to the extent of the aggregate amount paid in settlement of any litigation, or any … , as incurred (including the fees and disbursements of counsel), reasonably incurred in investigating, preparing or defending against any litigation, or any
424B5
NNOX
Nano-X Imaging Ltd.
7 Jun 24
Prospectus supplement for primary offering
5:06pm
in Ukraine;
potential litigation associated with our transactions;
the future trading price of our ordinary shares and impact of securities … conflict in Ukraine;
potential litigation associated with our transactions;
the future trading price of our ordinary shares and impact of securities
6-K
EX-99.1
NNOX
Nano-X Imaging Ltd.
28 May 24
Nanox Announces First Quarter of 2024 Financial Results and Provides Business Update
8:10am
and legal fees in connection with the class-action litigation and the SEC investigation. A reconciliation between GAAP and non-GAAP financial measures … to and the outcome of litigation Nanox is currently subject to and any similar or other claims and potential litigation it may be subject
POS AM
NNOX
Nano-X Imaging Ltd.
22 Apr 24
Prospectus update (post-effective amendment)
9:32am
in Ukraine;
potential litigation associated with our transactions;
the future trading price of our ordinary shares and impact of securities analysts
POSASR
EX-4.8
3c9ts96pjm4d03o
22 Apr 24
Automatic shelf registration (post-effective amendment)
9:20am
POSASR
ntd6mcd9ddfzap8ohq
22 Apr 24
Automatic shelf registration (post-effective amendment)
9:20am
6-K
bqq8u0
1 Apr 24
Nanox Announces Fourth Quarter of 2023 Financial Results and Provides Business Update
8:06am
6-K
EX-99.1
p4kws
1 Apr 24
Nanox Announces Fourth Quarter of 2023 Financial Results and Provides Business Update
8:06am
6-K
EX-99.1
tzhr20
13 Feb 24
Nanox Receives FDA Clearance for HealthFLD, an Advanced AI-Based Software Empowering Clinicians in Assessment of Fatty Liver
8:10am
6-K
EX-99.1
0kiorex3nflxlq19
16 Jan 24
Nanox Mourns Death of Its Founder, Ran Poliakine
8:35am
6-K
EX-99.1
g3oesadgj6bizr lcg
28 Nov 23
Nanox Announces Third Quarter of 2023 Financial Results and Provides Business Update
8:20am
6-K
9osqe ido0s
28 Nov 23
Nanox Announces Third Quarter of 2023 Financial Results and Provides Business Update
8:20am
6-K
EX-99.1
sr6gptj7t8vpr1mlo
3 Oct 23
Nanox Announces Strategic Manufacturing Agreement with Varex Imaging Corporation to Advance the Nanox.ARC Medical Imaging System
8:35am
6-K
w3g7xmrpwk
17 Aug 23
Nanox Announces Second Quarter of 2023 Financial Results and Provides Business Update
8:05am
6-K
EX-99.1
6fxvfnpbu1w7sodp
17 Aug 23
Nanox Announces Second Quarter of 2023 Financial Results and Provides Business Update
8:05am
6-K
EX-4.2
x9j4y
26 Jul 23
Report of Foreign Private Issuer
5:15pm
424B5
5vn6m31hpvrjo
26 Jul 23
Prospectus supplement for primary offering
9:06am
POSASR
ujbtv3t
26 Jul 23
Automatic shelf registration (post-effective amendment)
8:31am